When to start ART in adults? The results of HPTN 052 move us closer to a test-and-treat policy

When is the best time to initiate antiretroviral therapy (ART) in adults? This is a vital question in HIV treatment and prevention services. More specifically, is the 350 cells/µl CD4 count threshold recommended by current World Health Organization (WHO) guidelines sufficient, or should we move to a...

Full description

Saved in:
Bibliographic Details
Main Author: Nathan Geffen (Author)
Format: Book
Published: AOSIS, 2011-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ec4ad680e2b048bba5af8b7ca3ca3b8c
042 |a dc 
100 1 0 |a Nathan Geffen  |e author 
245 0 0 |a When to start ART in adults? The results of HPTN 052 move us closer to a test-and-treat policy 
260 |b AOSIS,   |c 2011-09-01T00:00:00Z. 
500 |a 1608-9693 
500 |a 2078-6751 
500 |a 10.4102/sajhivmed.v12i3.178 
520 |a When is the best time to initiate antiretroviral therapy (ART) in adults? This is a vital question in HIV treatment and prevention services. More specifically, is the 350 cells/µl CD4 count threshold recommended by current World Health Organization (WHO) guidelines sufficient, or should we move to a 'test-and-treat' approach in which anyone who tests HIV-positive is offered ART, irrespective of their CD4 count? The recently announced results of the HPTN 052 trial take us closer, but not all the way, to a test-and-treat approach. 
546 |a EN 
690 |a Public aspects of medicine 
690 |a RA1-1270 
690 |a Infectious and parasitic diseases 
690 |a RC109-216 
655 7 |a article  |2 local 
786 0 |n Southern African Journal of HIV Medicine, Vol 12, Iss 3 (2011) 
787 0 |n https://sajhivmed.org.za/index.php/hivmed/article/view/178 
787 0 |n https://doaj.org/toc/1608-9693 
787 0 |n https://doaj.org/toc/2078-6751 
856 4 1 |u https://doaj.org/article/ec4ad680e2b048bba5af8b7ca3ca3b8c  |z Connect to this object online.